Skip to navigation menu Skip to content
Clinical Trial Search block Test

A randomized trial of low versus moderate exposure busulfan for infants with severe combined immunodeficiency (SCID) receiving TCRαβ+/CD19+ depleted transplantation: A Phase II study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC) PIDTC “CSIDE” Protocol (Conditioning SCID Infants Diagnosed Early) PBMTC NMD 1801

8731 C-SIDE

What is the goal of the study?

Busulfan exposure-finding for SCID with TCRαβ+/CD19+ depleted transplantation

Who can participate in the study?

Everyone

Study Team: